We serve Chemical Name:4-(trifluoromethoxy)phenyl chlorothioformate CAS:2251-66-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(trifluoromethoxy)phenyl chlorothioformate
CAS.NO:2251-66-3
Synonyms:4-(trifluoromethoxy)phenyl chlorothioformate
Molecular Formula:C8H4ClF3O2S
Molecular Weight:256.6293696
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-(trifluoromethoxy)phenyl chlorothioformate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(trifluoromethoxy)phenyl chlorothioformate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(trifluoromethoxy)phenyl chlorothioformate Use and application,4-(trifluoromethoxy)phenyl chlorothioformate technical grade,usp/ep/jp grade.
Related News: Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 4-(trifluoromethoxy)phenyl chlorothioformate manufacturer While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added. 4-(trifluoromethoxy)phenyl chlorothioformate supplier With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines. 4-(trifluoromethoxy)phenyl chlorothioformate vendor Matthew Cheung, Hong Kong��s No. 2 official, appealed to medical workers to reconsider. ��At this critical moment, I believe the general public would count on medical personnel to fight against the epidemic together, in the spirit of professionalism,�� he wrote in a blog post on Sunday. 4-(trifluoromethoxy)phenyl chlorothioformate factory Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment.
